3D Systems (DDD) Announces CEO Jeffrey A. Graves to Retire; Severance Terms

What Happened

• 3D Systems Corporation (DDD) filed an 8‑K on August 4, 2026 announcing that President and CEO Dr. Jeffrey A. Graves will leave the company and retire from the Board once a successor CEO is hired. Dr. Graves will remain as CEO and on the Board until a successor is identified (expected later this year) and will then transition to a six‑month consulting role. The filing also references Item 2.02 (Results of Operations and Financial Condition) furnished in accordance with General Instruction B.2 of Form 8‑K. A press release announcing the change was furnished as Exhibit 99.1.

Key Details

• Dr. Graves will continue as CEO until a successor is hired and then serve as a consultant for 6 months, paid at his current monthly base salary.
• Severance Agreement provides upon termination: (i) cash equal to 150% of his current annual base salary, paid in 18 equal installments (first two installments paid on day 60 after termination); (ii) a lump sum equal to 50% of his current annual base salary paid on day 60 after termination; (iii) Company‑paid portion of medical premiums under COBRA for up to 18 months.
• Continued vesting: restricted stock awards scheduled to vest through April 2027 will continue to vest (subject to award terms and continued service); performance‑based RSUs from 2024 may remain eligible to vest in April 2027 subject to performance goals and continued service.
• Payments and benefits are contingent on Dr. Graves executing a full release of claims; he remains subject to existing confidentiality, noncompetition, noninterference and nonsolicitation obligations from his May 11, 2020 employment agreement.

Why It Matters

• Leadership change at the CEO level is a material corporate event that investors should watch; the company has begun a search for a successor CEO. The severance, consulting payments and continued vesting provisions could result in near‑term cash outlays and stock‑based compensation expense for 3D Systems if and when Dr. Graves’s employment terminates and the required releases are executed. Investors should monitor subsequent updates about the CEO search, timing of the transition, and any related impacts disclosed in future filings or earnings releases.